Research and Clinical Trials

Dr. Keith Knutson discusses lung cancer vaccine research at Mayo Clinic and how physicians might use vaccines for other types of cancer.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Mark McNiven, Ph.D., and Tanios Bekaii-Saab, M.D., Mayo Clinic Comprehensive Cancer Center researchers, explain what cancer is, how it develops and why it's challenging to treat.

Findings show extended progression-free survival for people with meningiomas who received a radiopharmaceutical approved for neuroendocrine tumors.

Mayo Clinic study findings reveal a protein that increases glioblastoma malignancy, a new understanding of the tumor's biology, and a potential new treatment strategy.

Dr. Elizabeth Cathcart-Rake explains the value of specialized cancer care for LGBTQ+ people and how she hopes to pave the way for improved outcomes with the Rainbows Breast Cancer Clinic.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

A new study shows people with monoclonal B-cell lymphocytosis (MBL) may have an elevated risk for several health complications, including melanoma.

After a history-making larynx transplant at Mayo Clinic, Marty Kedian is back home in the Boston area and drawing attention with his gift for gab.

New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection.